| Literature DB >> 29420986 |
Baris Turkbey1, Peter L Choyke2.
Abstract
MR imaging is an important part of prostate cancer diagnosis. Variations in quality and skill in general practice mean results are not as impressive as they were in academic centers. This observation provides an impetus to improve the method. Improved quality assurance will likely result in better outcomes. Improved characterization of clinically significant prostate cancer may assist in making MR imaging more useful. Improved methods of registering MR imaging with transrectal ultrasound imaging and robotic arms controlling the biopsy can reduce the impact of inexperienced operators and make the entire system of MR imaging-guided biopsies more robust. Published by Elsevier Inc.Entities:
Keywords: Clinically significant cancer; Imaging modalities; MR imaging; Prostate; Prostate cancer
Mesh:
Year: 2017 PMID: 29420986 PMCID: PMC5808592 DOI: 10.1016/j.rcl.2017.10.013
Source DB: PubMed Journal: Radiol Clin North Am ISSN: 0033-8389 Impact factor: 2.303